The M 3 -muscarinic receptor regulates learning and memory in a receptor phosphorylation/arrestin-dependent manner
Degeneration of the cholinergic system is considered to be the underlying pathology that results in the cognitive deficit in Alzheimer's disease. This pathology is thought to be linked to a loss of signaling through the cholinergic M 1 -muscarinic receptor subtype. However, recent studies have cast doubt on whether this is the primary receptor mediating cholinergic-hippocampal learning and memory. The current study offers an alternative mechanism involving the M 3 -muscarinic receptor that is expressed in numerous brain regions including the hippocampus. We demonstrate here that M 3 -muscarinic receptor knockout mice show a deficit in fear conditioning learning and memory. The mechanism used by the M 3 -muscarinic receptor in this process involves receptor phosphorylation because a knockin mouse strain expressing a phosphorylation-deficient receptor mutant also shows a deficit in fear conditioning. Consistent with a role for receptor phosphorylation, we demonstrate that the M 3 -muscarinic receptor is phosphorylated in the hippocampus following agonist treatment and following fear conditioning training. Importantly, the phosphorylation-deficient M 3 -muscarinic receptor was coupled normally to G q/11 -signaling but was uncoupled from phosphorylation-dependent processes such as receptor internalization and arrestin recruitment. It can, therefore, be concluded that M 3 -muscarinic receptor–dependent learning and memory depends, at least in part, on receptor phosphorylation/arrestin signaling. This study opens the potential for biased M 3 -muscarinic receptor ligands that direct phosphorylation/arrestin-dependent (non-G protein) signaling as being beneficial in cognitive disorders.
Топ-30
Журналы
|
1
2
3
4
5
6
7
|
|
|
Handbook of Experimental Pharmacology
7 публикаций, 5.26%
|
|
|
Behavioural Brain Research
4 публикации, 3.01%
|
|
|
Nature Reviews Drug Discovery
3 публикации, 2.26%
|
|
|
Neuropharmacology
3 публикации, 2.26%
|
|
|
Journal of Biological Chemistry
3 публикации, 2.26%
|
|
|
European Journal of Pharmacology
3 публикации, 2.26%
|
|
|
Neuromethods
3 публикации, 2.26%
|
|
|
Proceedings of the National Academy of Sciences of the United States of America
3 публикации, 2.26%
|
|
|
bioRxiv
3 публикации, 2.26%
|
|
|
Molecular Pharmacology
2 публикации, 1.5%
|
|
|
Brain Sciences
2 публикации, 1.5%
|
|
|
Frontiers in Aging Neuroscience
2 публикации, 1.5%
|
|
|
International Journal of Molecular Sciences
2 публикации, 1.5%
|
|
|
Nature Communications
2 публикации, 1.5%
|
|
|
Psychopharmacology
2 публикации, 1.5%
|
|
|
Neuropsychopharmacology
2 публикации, 1.5%
|
|
|
Brain Research Bulletin
2 публикации, 1.5%
|
|
|
Cellular Signalling
2 публикации, 1.5%
|
|
|
British Journal of Pharmacology
2 публикации, 1.5%
|
|
|
Journal of Pharmacological Sciences
2 публикации, 1.5%
|
|
|
Learning and Memory
2 публикации, 1.5%
|
|
|
Frontiers in Neuroscience
1 публикация, 0.75%
|
|
|
American Journal of Psychiatry
1 публикация, 0.75%
|
|
|
Pharmacological Reviews
1 публикация, 0.75%
|
|
|
Journal of Pharmacology and Experimental Therapeutics
1 публикация, 0.75%
|
|
|
American Journal of Respiratory Cell and Molecular Biology
1 публикация, 0.75%
|
|
|
Neurodegenerative disease management
1 публикация, 0.75%
|
|
|
Restorative Neurology and Neuroscience
1 публикация, 0.75%
|
|
|
Neuronal Signaling
1 публикация, 0.75%
|
|
|
1
2
3
4
5
6
7
|
Издатели
|
5
10
15
20
25
30
35
40
|
|
|
Elsevier
39 публикаций, 29.32%
|
|
|
Springer Nature
32 публикации, 24.06%
|
|
|
Wiley
8 публикаций, 6.02%
|
|
|
Frontiers Media S.A.
6 публикаций, 4.51%
|
|
|
MDPI
6 публикаций, 4.51%
|
|
|
American Society for Pharmacology and Experimental Therapeutics
4 публикации, 3.01%
|
|
|
Taylor & Francis
4 публикации, 3.01%
|
|
|
SAGE
3 публикации, 2.26%
|
|
|
American Society for Biochemistry and Molecular Biology
3 публикации, 2.26%
|
|
|
American Chemical Society (ACS)
3 публикации, 2.26%
|
|
|
Proceedings of the National Academy of Sciences (PNAS)
3 публикации, 2.26%
|
|
|
openRxiv
3 публикации, 2.26%
|
|
|
Portland Press
2 публикации, 1.5%
|
|
|
Cold Spring Harbor Laboratory
2 публикации, 1.5%
|
|
|
American Psychiatric Association Publishing
1 публикация, 0.75%
|
|
|
American Thoracic Society
1 публикация, 0.75%
|
|
|
IOS Press
1 публикация, 0.75%
|
|
|
Spandidos Publications
1 публикация, 0.75%
|
|
|
Ovid Technologies (Wolters Kluwer Health)
1 публикация, 0.75%
|
|
|
Baishideng Publishing Group
1 публикация, 0.75%
|
|
|
China Science Publishing & Media
1 публикация, 0.75%
|
|
|
Public Library of Science (PLoS)
1 публикация, 0.75%
|
|
|
King Saud University
1 публикация, 0.75%
|
|
|
Pleiades Publishing
1 публикация, 0.75%
|
|
|
Asian Pacific Journal of Tropical Medicine Press
1 публикация, 0.75%
|
|
|
Oxford University Press
1 публикация, 0.75%
|
|
|
Cambridge University Press
1 публикация, 0.75%
|
|
|
Annual Reviews
1 публикация, 0.75%
|
|
|
Society for Neuroscience
1 публикация, 0.75%
|
|
|
5
10
15
20
25
30
35
40
|
- Мы не учитываем публикации, у которых нет DOI.
- Статистика публикаций обновляется еженедельно.